Paul Dark

Paul Dark

Manchester University

H-index: 58

North America-United States

About Paul Dark

Paul Dark, With an exceptional h-index of 58 and a recent h-index of 49 (since 2020), a distinguished researcher at Manchester University, specializes in the field of emergency care, critical care, intensive care, health services research, humanitarianism.

His recent articles reflect a diverse array of research interests and contributions to the field:

Clinical descriptors of disease trajectories in patients with traumatic brain injury in the intensive care unit (CENTER-TBI): a multicentre observational cohort study

Early vs Late Fixation of Extremity Fractures Among Adults With Traumatic Brain Injury

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised …

Covariates in population pharmacokinetic studies of critically ill adults receiving β-lactam antimicrobials: a systematic review and narrative synthesis

Multimorbidity-associated emergency hospital admissions: a “screen and link” strategy to improve outcomes for high-risk patients in sub-Saharan Africa: a prospective …

Contrasting Characteristics and Outcomes of Sports-Related and Non–Sports-Related Traumatic Brain Injury

Causes, outcomes and diagnosis of acute breathlessness hospital admissions in Malawi: protocol for a multicentre prospective cohort study

Sepsis and case fatality rates and associations with deprivation, ethnicity, and clinical characteristics: population-based case–control study with linked primary care and …

Paul Dark Information

University

Position

___

Citations(all)

34104

Citations(since 2020)

31931

Cited By

3061

hIndex(all)

58

hIndex(since 2020)

49

i10Index(all)

118

i10Index(since 2020)

102

Email

University Profile Page

Google Scholar

Paul Dark Skills & Research Interests

emergency care

critical care

intensive care

health services research

humanitarianism

Top articles of Paul Dark

Covariates in population pharmacokinetic studies of critically ill adults receiving β-lactam antimicrobials: a systematic review and narrative synthesis

2024/2

Kayode Ogungbenro
Kayode Ogungbenro

H-Index: 16

Paul Dark
Paul Dark

H-Index: 21

Multimorbidity-associated emergency hospital admissions: a “screen and link” strategy to improve outcomes for high-risk patients in sub-Saharan Africa: a prospective …

NIHR Open Research

2024/1/18

Causes, outcomes and diagnosis of acute breathlessness hospital admissions in Malawi: protocol for a multicentre prospective cohort study

Wellcome Open Research

2024/4/17

Sepsis and case fatality rates and associations with deprivation, ethnicity, and clinical characteristics: population-based case–control study with linked primary care and …

Infection

2024/4/16

Immunomodulatory drugs in sepsis: a systematic review and meta‐analysis

2024/3/24

System-wide approaches to antimicrobial therapy and antimicrobial resistance in the UK: the AMR-X framework

Lancet Microbe

2024

Long COVID research: an update from the PHOSP-COVID Scientific Summit

The Lancet Respiratory Medicine

2023/11/1

Delayed Mucosal Antiviral Responses Despite Robust Peripheral Inflammation in Fatal COVID-19

The Journal of infectious diseases

2023/12/22

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

The Lancet Regional Health–Europe

2023/6/1

Developing a model for decision-making around antibiotic prescribing for patients with COVID-19 pneumonia in acute NHS hospitals during the first wave of the COVID-19 pandemic …

BMJ open

2023/12/1

Analysis of exhaled breath to identify critically ill patients with ventilator‐associated pneumonia

Anaesthesia

2023/6

Alternative pathway dysregulation in tissues drives sustained complement activation and predicts outcome across the disease course in COVID‐19

Immunology

2023/3

Alpha 2 agonists for sedation to produce better outcomes from critical illness (A2B Trial): protocol for a multicentre phase 3 pragmatic clinical and cost-effectiveness …

BMJ open

2023/12/1

See List of Professors in Paul Dark University(Manchester University)